Alto Neuroscience, Inc. (ANRO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 269.13M | 177.72M | 139.45M | 149.85M | 163.52M | 169.34M | 183.53M | 195.41M | 208.31M | 85.39M | 52.05M |
| Cash & Short-Term Investments | 263.76M | 176.48M | 137.82M | 147.59M | 160.75M | 168.23M | 181.7M | 193.12M | 205.9M | 82.55M | 51.29M |
| Cash Only | 263.76M | 176.48M | 137.82M | 147.59M | 160.75M | 168.23M | 181.7M | 193.12M | 205.9M | 82.55M | 51.29M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8K | 8K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.36M | 1.04M | 0 | 936K | 23K | 30K | 277K | 148K | 150K | 2.31M | 117K |
| Total Non-Current Assets | 7.13M | 6.97M | 7.56M | 8.03M | 8.39M | 8.21M | 8.08M | 1.95M | 1.61M | 1.24M | 1.19M |
| Property, Plant & Equipment | 6.29M | 6.13M | 6.49M | 6.96M | 7.32M | 7.7M | 7.58M | 1.44M | 1.55M | 1.11M | 987K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 500K | 0 | 500K | 500K | 500K | 500K | 500K | 0 | 0 | 0 |
| Other Non-Current Assets | 838K | 338K | 1.07M | 570K | 569K | 4K | 4K | 4K | 58K | 131K | 201K |
| Total Assets | 276.26M | 184.69M | 147.01M | 157.88M | 171.91M | 177.54M | 191.61M | 197.36M | 209.92M | 86.63M | 53.24M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 60.7% | 4.03% | -23.28% | -20.01% | -18.11% | 104.95% | 259.92% | - | - | - | - |
| Total Current Liabilities | 13.12M | 11.32M | 9.04M | 8.13M | 7.26M | 10.01M | 14.02M | 9.84M | 8.01M | 5.61M | 5.98M |
| Accounts Payable | 3.37M | 1.88M | 2.06M | 1.67M | 1.38M | 1.58M | 2.25M | 1.84M | 2.41M | 1.07M | 1.76M |
| Days Payables Outstanding | 1.28K | - | - | 1.39K | - | 1.04K | - | - | 1.64K | 1.42K | - |
| Short-Term Debt | 2.14M | 1.74M | 0 | 973K | 0 | 0 | 3.53M | 2.32M | 1.15M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.61M | 2.84M | 0 | 2.69M | 0 | 2.61M | 0 | 0 | 2.79M | 0 | 185K |
| Current Ratio | 20.52x | 15.69x | 15.42x | 18.43x | 22.53x | 16.92x | 13.09x | 19.85x | 26.02x | 15.22x | 8.70x |
| Quick Ratio | 20.52x | 15.69x | 15.42x | 18.43x | 22.53x | 16.92x | 13.09x | 19.85x | 26.02x | 15.22x | 8.70x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 19.77M | 22.22M | 26.4M | 26.34M | 25.56M | 16.07M | 12.54M | 7.74M | 8.81M | 152.69M | 108.35M |
| Long-Term Debt | 3.56M | 18.4M | 22.44M | 22.12M | 21.15M | 11.56M | 7.92M | 7.74M | 8.81M | 9.86M | 9.76M |
| Capital Lease Obligations | 0 | 3.82M | 3.97M | 4.21M | 4.41M | 4.52M | 4.62M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 16.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 142.83M | 98.6M |
| Total Liabilities | 32.89M | 33.55M | 35.45M | 34.47M | 32.82M | 26.08M | 26.56M | 17.58M | 16.82M | 158.3M | 114.33M |
| Total Debt | 5.69M | 23.96M | 27.52M | 27.31M | 26.44M | 16.94M | 16.79M | 10.06M | 10.01M | 9.99M | 9.95M |
| Net Debt | -258.07M | -152.53M | -110.29M | -120.28M | -134.32M | -151.28M | -164.91M | -183.06M | -195.88M | -72.56M | -41.34M |
| Debt / Equity | 0.02x | 0.16x | 0.25x | 0.22x | 0.19x | 0.11x | 0.10x | 0.06x | 0.05x | - | - |
| Debt / EBITDA | - | 0.21x | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | -1.32x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -49.79x | -27.14x | -20.82x | -26.41x | -24.37x | -44.65x | -47.09x | -45.20x | -37.78x | -30.51x | -24.18x |
| Total Equity | 243.37M | 151.14M | 111.56M | 123.41M | 139.1M | 151.46M | 165.05M | 179.78M | 193.1M | -71.67M | -61.1M |
| Equity Growth % | 74.96% | -0.21% | -32.41% | -31.35% | -27.97% | 311.32% | 370.15% | - | - | - | - |
| Book Value per Share | 7.40 | 4.73 | 4.12 | 4.56 | 5.14 | 5.61 | 6.12 | 6.67 | 7.18 | -2.67 | -2.27 |
| Total Shareholders' Equity | 243.37M | 151.14M | 111.56M | 123.41M | 139.1M | 151.46M | 165.05M | 179.78M | 193.1M | -71.67M | -61.1M |
| Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 0 | 0 |
| Retained Earnings | -227.87M | -201.63M | -185.45M | -171.27M | -153.56M | -138.4M | -123.19M | -106.41M | -90.38M | -76.97M | -65.75M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 13K | 22K | 14K | 31K | 14K | -101K | -95K | -89K | -84K | -79K | -86K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |